190 related articles for article (PubMed ID: 24114443)
21. Protein lysine acetylation guards metabolic homeostasis to fight against cancer.
Xu W; Li Y; Liu C; Zhao S
Oncogene; 2014 May; 33(18):2279-85. PubMed ID: 23665675
[TBL] [Abstract][Full Text] [Related]
22. Dysregulated metabolism contributes to oncogenesis.
Hirschey MD; DeBerardinis RJ; Diehl AME; Drew JE; Frezza C; Green MF; Jones LW; Ko YH; Le A; Lea MA; Locasale JW; Longo VD; Lyssiotis CA; McDonnell E; Mehrmohamadi M; Michelotti G; Muralidhar V; Murphy MP; Pedersen PL; Poore B; Raffaghello L; Rathmell JC; Sivanand S; Vander Heiden MG; Wellen KE;
Semin Cancer Biol; 2015 Dec; 35 Suppl():S129-S150. PubMed ID: 26454069
[TBL] [Abstract][Full Text] [Related]
23. Succinate dehydrogenase and fumarate hydratase: linking mitochondrial dysfunction and cancer.
King A; Selak MA; Gottlieb E
Oncogene; 2006 Aug; 25(34):4675-82. PubMed ID: 16892081
[TBL] [Abstract][Full Text] [Related]
24. Metabolic changes in cancer: beyond the Warburg effect.
Wu W; Zhao S
Acta Biochim Biophys Sin (Shanghai); 2013 Jan; 45(1):18-26. PubMed ID: 23257292
[TBL] [Abstract][Full Text] [Related]
25. Anion-exchange chromatography mass spectrometry provides extensive coverage of primary metabolic pathways revealing altered metabolism in IDH1 mutant cells.
Walsby-Tickle J; Gannon J; Hvinden I; Bardella C; Abboud MI; Nazeer A; Hauton D; Pires E; Cadoux-Hudson T; Schofield CJ; McCullagh JSO
Commun Biol; 2020 May; 3(1):247. PubMed ID: 32433536
[TBL] [Abstract][Full Text] [Related]
26. Cancer cell metabolism connects epigenetic modifications to transcriptional regulation.
Morrison AJ
FEBS J; 2022 Mar; 289(5):1302-1314. PubMed ID: 34036737
[TBL] [Abstract][Full Text] [Related]
27. Fumarate hydratase in cancer: A multifaceted tumour suppressor.
Schmidt C; Sciacovelli M; Frezza C
Semin Cell Dev Biol; 2020 Feb; 98():15-25. PubMed ID: 31085323
[TBL] [Abstract][Full Text] [Related]
28. Oncometabolites-driven tumorigenesis: From genetics to targeted therapy.
Morin A; Letouzé E; Gimenez-Roqueplo AP; Favier J
Int J Cancer; 2014 Nov; 135(10):2237-48. PubMed ID: 25124653
[TBL] [Abstract][Full Text] [Related]
29. A highly facile and specific assay for cancer-causing isocitrate dehydrogenase mutant using 13C4-labeled α-ketoglutarate and heteronuclear NMR.
Wen H; Yun T; Xu WJ; Choi SH; Kim H; Park CK; Lee SH; Park SW; Lee SK; Park S
Anal Chem; 2013 Dec; 85(24):11987-92. PubMed ID: 24266712
[TBL] [Abstract][Full Text] [Related]
30. Metabolic quirks yield tumour hope.
Ledford H
Nature; 2014 Apr; 508(7495):158-9. PubMed ID: 24717486
[No Abstract] [Full Text] [Related]
31. [Epigenetic alterations and biological phenomena caused by mutation in an IDH gene].
Sasaki M
Seikagaku; 2016 Jun; 88(3):287-95. PubMed ID: 27483945
[No Abstract] [Full Text] [Related]
32. SDH5 mutations and familial paraganglioma: somewhere Warburg is smiling.
Kaelin WG
Cancer Cell; 2009 Sep; 16(3):180-2. PubMed ID: 19732718
[TBL] [Abstract][Full Text] [Related]
33. Targeting the interplay between metabolism and epigenetics in cancer.
Montellier E; Gaucher J
Curr Opin Oncol; 2019 Mar; 31(2):92-99. PubMed ID: 30562315
[TBL] [Abstract][Full Text] [Related]
34. [The enzymes of methanol and methylamine metabolism in Pseudomonas methylica].
Loginova NV; Trotsenko IuA
Mikrobiologiia; 1974; 43(6):979-85. PubMed ID: 4375248
[No Abstract] [Full Text] [Related]
35. Metabolic Enzymes in Sarcomagenesis: Progress Toward Biology and Therapy.
Li L; Eid JE; Paz AC; Trent JC
BioDrugs; 2017 Oct; 31(5):379-392. PubMed ID: 28840584
[TBL] [Abstract][Full Text] [Related]
36. Fumarate reductase superfamily: A diverse group of enzymes whose evolution is correlated to the establishment of different metabolic pathways.
Jardim-Messeder D; Cabreira-Cagliari C; Rauber R; Turchetto-Zolet AC; Margis R; Margis-Pinheiro M
Mitochondrion; 2017 May; 34():56-66. PubMed ID: 28088649
[TBL] [Abstract][Full Text] [Related]
37. Isocitrate dehydrogenase mutations in chondrosarcoma: the crossroads between cellular metabolism and oncogenesis.
Azzi G; Velez M; Mathias-Machado MC
Curr Opin Oncol; 2014 Jul; 26(4):403-7. PubMed ID: 24867810
[TBL] [Abstract][Full Text] [Related]
38. Biochemical assays for mitochondrial activity: assays of TCA cycle enzymes and PDHc.
Reisch AS; Elpeleg O
Methods Cell Biol; 2007; 80():199-222. PubMed ID: 17445696
[No Abstract] [Full Text] [Related]
39. Heterogeneity of tumor-induced gene expression changes in the human metabolic network.
Hu J; Locasale JW; Bielas JH; O'Sullivan J; Sheahan K; Cantley LC; Vander Heiden MG; Vitkup D
Nat Biotechnol; 2013 Jun; 31(6):522-9. PubMed ID: 23604282
[TBL] [Abstract][Full Text] [Related]
40. Metabolic syndromes and malignant transformation: where the twain shall meet.
Bhagwat N; Levine RL
Sci Transl Med; 2010 Oct; 2(54):54ps50. PubMed ID: 20962328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
